145 related articles for article (PubMed ID: 35152178)
1. Induced pluripotent stem cell line ICGi038-A, obtained by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia due to compound heterozygous c.1246C > T/c.940 + 3_940 + 6del mutations in LDLR.
Zakharova IS; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Zubkova ES; Sleptcov AA; Nazarenko MS; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Stem Cell Res; 2022 Apr; 60():102702. PubMed ID: 35152178
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell line ICGi037-A, obtained by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia due to heterozygous p.Trp443Arg mutations in LDLR.
Zakharova IS; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Kalinin AP; Sleptcov AA; Nazarenko MS; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Stem Cell Res; 2022 Apr; 60():102703. PubMed ID: 35152179
[TBL] [Abstract][Full Text] [Related]
3. An integration-free iPSC line ZZUNEUi029-A derived from peripheral blood mononuclear cells of a patient with familial hypercholesterolemia carrying a mutation in LDLR gene.
Zhu K; Zhao J; Qin F; Chen X; Xu H; Li X; Tao H
Stem Cell Res; 2023 Sep; 71():103182. PubMed ID: 37586167
[TBL] [Abstract][Full Text] [Related]
4. Cohort Generation and Characterization of Patient-Specific Familial Hypercholesterolemia Induced Pluripotent Stem Cells.
Omer L; Hudson EA; Hudgins LC; Boyd NL
Stem Cells Dev; 2021 Jun; 30(12):632-640. PubMed ID: 34029164
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
[TBL] [Abstract][Full Text] [Related]
6. Restoration of Physiologically Responsive Low-Density Lipoprotein Receptor-Mediated Endocytosis in Genetically Deficient Induced Pluripotent Stem Cells.
Ramakrishnan VM; Yang JY; Tien KT; McKinley TR; Bocard BR; Maijub JG; Burchell PO; Williams SK; Morris ME; Hoying JB; Wade-Martins R; West FD; Boyd NL
Sci Rep; 2015 Aug; 5():13231. PubMed ID: 26307169
[TBL] [Abstract][Full Text] [Related]
7. Generation of a human iPSC line CIBi009-A from a patient with familial hypercholesterolemia carrying variants of LDLR c.T1241G and APOB c.G1618T.
Ge W; Song Y; Chu M; Liu Y; Yang B; Wang K; Yu B; Song C; Wang Y; Yang J
Stem Cell Res; 2021 May; 53():102347. PubMed ID: 33892292
[TBL] [Abstract][Full Text] [Related]
8. Generation of Human Liver Chimeric Mice with Hepatocytes from Familial Hypercholesterolemia Induced Pluripotent Stem Cells.
Yang J; Wang Y; Zhou T; Wong LY; Tian XY; Hong X; Lai WH; Au KW; Wei R; Liu Y; Cheng LH; Liang G; Huang Z; Fan W; Zhao P; Wang X; Ibañez DP; Luo Z; Li Y; Zhong X; Chen S; Wang D; Li L; Lai L; Qin B; Bao X; Hutchins AP; Siu CW; Huang Y; Esteban MA; Tse HF
Stem Cell Reports; 2017 Mar; 8(3):605-618. PubMed ID: 28262545
[TBL] [Abstract][Full Text] [Related]
9. iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.
Zakharova IS; Shevchenko AI; Arssan MA; Sleptcov AA; Nazarenko MS; Zarubin AA; Zheltysheva NV; Shevchenko VA; Tmoyan NA; Saaya SB; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255763
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cell line ICGi036-A generated by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia caused due to compound heterozygous p.Ser177Leu/p.Cys352Arg mutations in LDLR.
Zakharova IS; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Zubkova ES; Sleptcov AA; Nazarenko MS; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Stem Cell Res; 2022 Mar; 59():102653. PubMed ID: 34999421
[TBL] [Abstract][Full Text] [Related]
11. A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes.
Yang J; Wong LY; Tian XY; Wei R; Lai WH; Au KW; Luo Z; Ward C; Ho WI; Ibañez DP; Liu H; Bao X; Qin B; Huang Y; Esteban MA; Tse HF
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30272645
[TBL] [Abstract][Full Text] [Related]
12. Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.
Al-Allaf FA; Alashwal A; Abduljaleel Z; Taher MM; Bouazzaoui A; Abalkhail H; Al-Allaf AF; Athar M
Acta Biochim Pol; 2017; 64(1):75-79. PubMed ID: 27878139
[TBL] [Abstract][Full Text] [Related]
13. Calling and Phasing of Single-Nucleotide and Structural Variants of the
Nazarenko MS; Sleptcov AA; Zarubin AA; Salakhov RR; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Zubkova ES; Zheltysheva NV; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM; Zakharova IS
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901902
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
[TBL] [Abstract][Full Text] [Related]
15. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
[TBL] [Abstract][Full Text] [Related]
16. Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia.
Pisciotta L; Priore Oliva C; Cefalù AB; Noto D; Bellocchio A; Fresa R; Cantafora A; Patel D; Averna M; Tarugi P; Calandra S; Bertolini S
Atherosclerosis; 2006 Jun; 186(2):433-40. PubMed ID: 16183066
[TBL] [Abstract][Full Text] [Related]
17. [Mutation screening and functional analysis of low density lipoprotein receptor in a familial hypercholesterolemia family].
Cheng XH; Zheng F; Zhou X; Xiong CL; Ding J; Chen YM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):55-8. PubMed ID: 18247305
[TBL] [Abstract][Full Text] [Related]
18. Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene.
Jiang L; Benito-Vicente A; Tang L; Etxebarria A; Cui W; Uribe KB; Pan XD; Ostolaza H; Yang SW; Zhou YJ; Martin C; Wang LY
Atherosclerosis; 2017 Aug; 263():163-170. PubMed ID: 28645073
[TBL] [Abstract][Full Text] [Related]
19. Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review.
Mohd Nor NS; Al-Khateeb AM; Chua YA; Mohd Kasim NA; Mohd Nawawi H
BMC Pediatr; 2019 Apr; 19(1):106. PubMed ID: 30975109
[TBL] [Abstract][Full Text] [Related]
20. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
